Fertility Preservation in Gynecologic Cancers: Oncofertility Strategies, Ethical Dilemmas, and Clinical Outcomes
Keywords:
Oncofertility, ovarian tissue cryopreservation, radical trachelectomy, endometrial cancer conservative treatment, GnRH analogues, fertility-sparing surgery, premature ovarian insufficiency, reproductive counseling, gynecologic malignancyAbstract
Background
Gynecologic malignancies, including cervical, endometrial, and ovarian cancers, are increasingly diagnosed in women of reproductive age. As survival rates improve through advances in oncology, the preservation of fertility has become a central concern for both patients and clinicians. Oncofertility, the intersection of oncology and reproductive medicine, offers a range of strategies to protect reproductive potential without compromising oncologic outcomes.
Objectives
This narrative review aims to critically evaluate the evidence supporting current oncofertility strategies in gynecologic cancers, examine ethical dilemmas inherent to this field, assess counseling challenges, and synthesize clinical outcomes from published literature across the domains of ovarian tissue cryopreservation, fertility-sparing surgery, conservative endometrial management, and gonadotropin-releasing hormone (GnRH) analogue co-treatment.
Methods
A structured narrative review was conducted using PubMed, MEDLINE, EMBASE, and Cochrane databases. Search terms included combinations of: fertility preservation, oncofertility, gynecologic malignancies, ovarian tissue cryopreservation, radical trachelectomy, endometrial cancer conservative treatment, GnRH analogues chemotherapy, and reproductive counseling. Articles published between 2004 and 2024 were included. Randomized controlled trials, systematic reviews, meta-analyses, prospective cohort studies, and evidence-based clinical guidelines were prioritized.
Results
Ovarian tissue cryopreservation and transplantation has achieved cumulative live birth rates of approximately 25 to 40 percent, with over 200 live births reported globally. Radical vaginal trachelectomy in early-stage cervical cancer (Stage IB1) yields pregnancy rates of approximately 54 percent and recurrence rates comparable to radical hysterectomy in properly selected patients. Progestin-based conservative therapy for grade 1 endometrial carcinoma achieves regression in 76 to 82 percent of cases,
Downloads
Published
License
Copyright (c) 2026 Copyright © 2026 by the Author(s). Published by Neo-ART Excellence Hub Pvt. Ltd. This article is distributed under the Creative Commons Attribution 4.0 License (CC BY 4.0). Authors retain copyright and grant the publisher the right to publish and distribute the work. https://creativecommons.org/licenses/by/4.0/

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in the Journal of Clinical and Advanced Medicine (JCAM) are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
This license allows anyone to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, even commercially, as long as appropriate credit is given to the original author(s) and the source.
License link: https://creativecommons.org/licenses/by/4.0/